Impact of Muscarinic M(3) Receptor Antagonism on the Risk of Type 2 Diabetes in Antidepressant-Treated Patients: A Case-Controlled Study

BACKGROUND: M(3) muscarinic receptor antagonism has been associated with glucose intolerance and disturbance of insulin secretion. OBJECTIVE: Our objective was to examine the risk of type 2 diabetes mellitus (T2DM) in patients using antidepressants with and without M(3) muscarinic receptor antagonis...

Descripción completa

Detalles Bibliográficos
Autores principales: Tran, Yen-Hao, Schuiling-Veninga, Catharina C. M., Bergman, Jorieke E. H., Groen, Henk, Wilffert, Bob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5488147/
https://www.ncbi.nlm.nih.gov/pubmed/28527131
http://dx.doi.org/10.1007/s40263-017-0436-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5488147/
https://www.ncbi.nlm.nih.gov/pubmed/28527131
http://dx.doi.org/10.1007/s40263-017-0436-x

Ejemplares similares